| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.60e-04 | 190 | 54 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 2.39e-04 | 207 | 54 | 5 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.67e-04 | 212 | 54 | 5 | GO:0017171 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 3.89e-04 | 11 | 54 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | calcium ion binding | 8.53e-04 | 749 | 54 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.04e-03 | 430 | 54 | 6 | GO:0004175 | |
| Domain | PAN | 7.07e-07 | 7 | 52 | 3 | PS50948 | |
| Domain | Pan_app | 7.07e-07 | 7 | 52 | 3 | IPR003609 | |
| Domain | PAN_1 | 7.07e-07 | 7 | 52 | 3 | PF00024 | |
| Domain | Peptidase_S1A | 1.54e-05 | 113 | 52 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.67e-05 | 115 | 52 | 5 | PS50240 | |
| Domain | Tryp_SPc | 1.82e-05 | 117 | 52 | 5 | SM00020 | |
| Domain | Trypsin | 2.14e-05 | 121 | 52 | 5 | PF00089 | |
| Domain | Trypsin_dom | 2.14e-05 | 121 | 52 | 5 | IPR001254 | |
| Domain | Peptidase_S1_PA | 2.32e-05 | 123 | 52 | 5 | IPR009003 | |
| Domain | PAN_AP | 7.56e-05 | 5 | 52 | 2 | SM00473 | |
| Domain | EGF_CA | 9.58e-05 | 86 | 52 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.53e-04 | 97 | 52 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.65e-04 | 99 | 52 | 4 | PS01187 | |
| Domain | ConA-like_dom | 3.52e-04 | 219 | 52 | 5 | IPR013320 | |
| Domain | EGF_CA | 3.68e-04 | 122 | 52 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.92e-04 | 124 | 52 | 4 | IPR001881 | |
| Domain | EGF | 4.16e-04 | 126 | 52 | 4 | PF00008 | |
| Domain | EGF_3 | 4.85e-04 | 235 | 52 | 5 | PS50026 | |
| Domain | EGF | 4.85e-04 | 235 | 52 | 5 | SM00181 | |
| Domain | EGF-like_dom | 6.31e-04 | 249 | 52 | 5 | IPR000742 | |
| Domain | EGF_1 | 7.02e-04 | 255 | 52 | 5 | PS00022 | |
| Domain | EGF-like_CS | 7.80e-04 | 261 | 52 | 5 | IPR013032 | |
| Domain | EGF_2 | 8.35e-04 | 265 | 52 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 9.28e-04 | 156 | 52 | 4 | IPR009030 | |
| Domain | Kringle | 1.01e-03 | 17 | 52 | 2 | IPR000001 | |
| Domain | Kringle_CS | 1.01e-03 | 17 | 52 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 1.01e-03 | 17 | 52 | 2 | PS50070 | |
| Domain | Kringle | 1.01e-03 | 17 | 52 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 1.01e-03 | 17 | 52 | 2 | PS00021 | |
| Domain | KR | 1.01e-03 | 17 | 52 | 2 | SM00130 | |
| Domain | SPRY | 1.83e-03 | 87 | 52 | 3 | SM00449 | |
| Domain | TRYPSIN_SER | 2.02e-03 | 90 | 52 | 3 | IPR033116 | |
| Domain | SPRY | 2.28e-03 | 94 | 52 | 3 | PF00622 | |
| Domain | SPRY_dom | 2.28e-03 | 94 | 52 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 2.35e-03 | 95 | 52 | 3 | IPR001870 | |
| Domain | B302_SPRY | 2.35e-03 | 95 | 52 | 3 | PS50188 | |
| Domain | ASX_HYDROXYL | 2.72e-03 | 100 | 52 | 3 | PS00010 | |
| Domain | TRYPSIN_HIS | 2.96e-03 | 103 | 52 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 3.21e-03 | 106 | 52 | 3 | PS00135 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.21e-03 | 106 | 52 | 3 | IPR000152 | |
| Domain | TRYPSIN_HIS | 3.30e-03 | 107 | 52 | 3 | PS00134 | |
| Domain | Kringle-like | 3.57e-03 | 32 | 52 | 2 | IPR013806 | |
| Domain | GPS | 4.03e-03 | 34 | 52 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 4.03e-03 | 34 | 52 | 2 | IPR017983 | |
| Domain | GPS | 4.27e-03 | 35 | 52 | 2 | PF01825 | |
| Domain | GPS | 4.51e-03 | 36 | 52 | 2 | PS50221 | |
| Domain | GPS | 4.76e-03 | 37 | 52 | 2 | IPR000203 | |
| Domain | SET | 5.82e-03 | 41 | 52 | 2 | PF00856 | |
| Domain | PRY | 6.10e-03 | 42 | 52 | 2 | PF13765 | |
| Domain | SET | 7.28e-03 | 46 | 52 | 2 | SM00317 | |
| Domain | PRY | 7.90e-03 | 48 | 52 | 2 | SM00589 | |
| Domain | PRY | 7.90e-03 | 48 | 52 | 2 | IPR006574 | |
| Domain | CUB | 8.22e-03 | 49 | 52 | 2 | PF00431 | |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 1.17e-04 | 6 | 40 | 2 | MM15492 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 1.63e-04 | 7 | 40 | 2 | MM1580 | |
| Pathway | WP_MIR302367_PROMOTING_CARDIOMYOCYTE_PROLIFERATION | 2.17e-04 | 8 | 40 | 2 | MM15986 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10728827 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16961763 | ||
| Pubmed | Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. | 2.46e-06 | 2 | 55 | 2 | 39253972 | |
| Pubmed | Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway. | 2.46e-06 | 2 | 55 | 2 | 29760744 | |
| Pubmed | Characterization of free alpha- and beta-chains of recombinant macrophage-stimulating protein. | 2.46e-06 | 2 | 55 | 2 | 10068459 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 32017081 | ||
| Pubmed | Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. | 2.46e-06 | 2 | 55 | 2 | 30708325 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24409221 | ||
| Pubmed | Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1. | 2.46e-06 | 2 | 55 | 2 | 27696525 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8393443 | ||
| Pubmed | Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. | 2.46e-06 | 2 | 55 | 2 | 8340069 | |
| Pubmed | Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. | 2.46e-06 | 2 | 55 | 2 | 9486989 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 27609031 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24980820 | ||
| Pubmed | Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice. | 2.46e-06 | 2 | 55 | 2 | 33887258 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25938541 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31206688 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 27496379 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 12804176 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 12606483 | ||
| Pubmed | The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. | 7.36e-06 | 3 | 55 | 2 | 10225971 | |
| Pubmed | Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice. | 7.36e-06 | 3 | 55 | 2 | 36623453 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 37184367 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 38430683 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 12538524 | ||
| Pubmed | Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. | 7.36e-06 | 3 | 55 | 2 | 19339990 | |
| Pubmed | TRAF2 functions as an activator switch in the reactive oxygen species-induced stimulation of MST1. | 7.36e-06 | 3 | 55 | 2 | 26698664 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 38288506 | ||
| Pubmed | The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. | 7.36e-06 | 3 | 55 | 2 | 8545120 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 25049204 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 1832957 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 25183307 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 35525373 | ||
| Pubmed | MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. | 7.36e-06 | 3 | 55 | 2 | 27510910 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 30063115 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 31976559 | ||
| Pubmed | Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. | 7.36e-06 | 3 | 55 | 2 | 27218122 | |
| Pubmed | Over-expressed MST1 impaired spatial memory via disturbing neural oscillation patterns in mice. | 7.36e-06 | 3 | 55 | 2 | 32468668 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 17395874 | ||
| Pubmed | Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1. | 7.36e-06 | 3 | 55 | 2 | 29127009 | |
| Pubmed | Mst1 Kinase Regulates the Actin-Bundling Protein L-Plastin To Promote T Cell Migration. | 7.36e-06 | 3 | 55 | 2 | 27465533 | |
| Pubmed | Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. | 7.36e-06 | 3 | 55 | 2 | 24852423 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 30771091 | ||
| Pubmed | MST1 mediates the N-methyl-D-aspartate-induced excitotoxicity in mouse cortical neurons. | 7.36e-06 | 3 | 55 | 2 | 34967918 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 38898027 | ||
| Pubmed | WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. | 7.36e-06 | 3 | 55 | 2 | 32045478 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 27940445 | ||
| Pubmed | Mst1 regulates hepatic lipid metabolism by inhibiting Sirt1 ubiquitination in mice. | 1.47e-05 | 4 | 55 | 2 | 26903296 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 23527007 | ||
| Pubmed | A cell-intrinsic role for Mst1 in regulating thymocyte egress. | 1.47e-05 | 4 | 55 | 2 | 19692642 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 21078906 | ||
| Pubmed | MST1 controls murine neutrophil homeostasis via the G-CSFR/STAT3 axis. | 1.47e-05 | 4 | 55 | 2 | 36618429 | |
| Pubmed | Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling. | 1.47e-05 | 4 | 55 | 2 | 28480597 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 16892067 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 25659841 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 35715527 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 26538561 | ||
| Pubmed | MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS. | 1.47e-05 | 4 | 55 | 2 | 23818595 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 25074980 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 35626096 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 22926556 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 27825852 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 32987643 | ||
| Pubmed | The Mst1 Kinase Is Required for Follicular B Cell Homing and B-1 B Cell Development. | 1.47e-05 | 4 | 55 | 2 | 30386341 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 28527887 | ||
| Pubmed | Mst1 directs Myosin IIa partitioning of low and higher affinity integrins during T cell migration. | 1.47e-05 | 4 | 55 | 2 | 25133611 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 32627655 | ||
| Pubmed | Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4. | 1.47e-05 | 4 | 55 | 2 | 34515499 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 9846490 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 27919044 | ||
| Pubmed | Mst1/2 Kinases Modulate Glucose Uptake for Osteoblast Differentiation and Bone Formation. | 1.47e-05 | 4 | 55 | 2 | 29474739 | |
| Pubmed | mTORC2 regulates cardiac response to stress by inhibiting MST1. | 1.47e-05 | 4 | 55 | 2 | 25843706 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 22412158 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 14734766 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 23085515 | ||
| Pubmed | Functional role of Mst1/Mst2 in embryonic stem cell differentiation. | 1.47e-05 | 4 | 55 | 2 | 24224013 | |
| Pubmed | Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. | 2.45e-05 | 5 | 55 | 2 | 20080689 | |
| Pubmed | Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus. | 2.45e-05 | 5 | 55 | 2 | 23033074 | |
| Pubmed | Assignment of the gene coding for hepatocyte growth factor-like protein to mouse chromosome 9. | 2.45e-05 | 5 | 55 | 2 | 1354648 | |
| Pubmed | The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. | 2.45e-05 | 5 | 55 | 2 | 19073936 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 29674007 | ||
| Pubmed | Mst1-Deficiency Induces Hyperactivation of Monocyte-Derived Dendritic Cells via Akt1/c-myc Pathway. | 2.45e-05 | 5 | 55 | 2 | 31572367 | |
| Pubmed | Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms. | 2.45e-05 | 5 | 55 | 2 | 32253273 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 36646002 | ||
| Pubmed | A single transcription factor is sufficient to induce and maintain secretory cell architecture. | 2.45e-05 | 5 | 55 | 2 | 28174210 | |
| Pubmed | A critical role for NF2 and the Hippo pathway in branching morphogenesis. | 2.57e-05 | 36 | 55 | 3 | 27480037 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 10803852 | ||
| Pubmed | Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. | 3.67e-05 | 6 | 55 | 2 | 21572393 | |
| Pubmed | Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice. | 3.67e-05 | 6 | 55 | 2 | 19956688 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 32929029 | ||
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 8325648 | ||
| Pubmed | Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL. | 3.67e-05 | 6 | 55 | 2 | 24813943 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 27701149 | ||
| Pubmed | MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. | 5.13e-05 | 7 | 55 | 2 | 18328708 | |
| Pubmed | 5.13e-05 | 7 | 55 | 2 | 24837172 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 22694956 | ||
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 21943708 | ||
| Pubmed | Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass. | 1.10e-04 | 10 | 55 | 2 | 26378466 | |
| Pubmed | 1.10e-04 | 10 | 55 | 2 | 9670959 | ||
| Pubmed | A collection of cDNAs enriched in upper cortical layers of the embryonic mouse brain. | 1.14e-04 | 59 | 55 | 3 | 15010206 | |
| Cytoband | 9q34.3 | 2.88e-04 | 106 | 55 | 3 | 9q34.3 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.96e-03 | 34 | 35 | 2 | 487 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.71e-03 | 40 | 35 | 2 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.44e-03 | 57 | 35 | 2 | 1179 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 4.57e-06 | 198 | 55 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_CTL|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.79e-05 | 162 | 55 | 4 | d53de64df2511eddba79f899fc3f48b1b059923f | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-05 | 165 | 55 | 4 | ebd668e87e5961a124d1d6fc25d1f03e4af05cd4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 168 | 55 | 4 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 168 | 55 | 4 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.64e-05 | 169 | 55 | 4 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.64e-05 | 169 | 55 | 4 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.64e-05 | 169 | 55 | 4 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.64e-05 | 169 | 55 | 4 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 170 | 55 | 4 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 6.04e-05 | 172 | 55 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 6.04e-05 | 172 | 55 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 6.32e-05 | 174 | 55 | 4 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 6.46e-05 | 175 | 55 | 4 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 6.46e-05 | 175 | 55 | 4 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 6.46e-05 | 175 | 55 | 4 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 177 | 55 | 4 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 177 | 55 | 4 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 55 | 4 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 55 | 4 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 6.75e-05 | 177 | 55 | 4 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 6.90e-05 | 178 | 55 | 4 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 7.05e-05 | 179 | 55 | 4 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 7.21e-05 | 180 | 55 | 4 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 7.36e-05 | 181 | 55 | 4 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-05 | 182 | 55 | 4 | 01ae44b465e509b0aa75ccf61bd9bc0a89d6758c | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 7.85e-05 | 184 | 55 | 4 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 185 | 55 | 4 | 39f2b7a35253968f6d744c10ece1478a05cf24da | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.01e-05 | 185 | 55 | 4 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | IIH-NK|IIH / Condition, Cell_class and T cell subcluster | 8.18e-05 | 186 | 55 | 4 | cab1249b849013cf0334f25ee8d840f0521f4eb8 | |
| ToppCell | IIH-NK-|IIH / Condition, Cell_class and T cell subcluster | 8.18e-05 | 186 | 55 | 4 | 2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 187 | 55 | 4 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.52e-05 | 188 | 55 | 4 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.52e-05 | 188 | 55 | 4 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.52e-05 | 188 | 55 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 8.70e-05 | 189 | 55 | 4 | 6c2ace61a7d62bcf7e76b73e2da8b722d03e713b | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-05 | 189 | 55 | 4 | 31d34bc75d4457fca197e1766922e987dbd5f8a9 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 9.06e-05 | 191 | 55 | 4 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.00e-04 | 196 | 55 | 4 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.00e-04 | 196 | 55 | 4 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | (5)_Fibroblast-J_(Lipofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.00e-04 | 196 | 55 | 4 | afa29399decd17fda7d63add5039ff778627ccc2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 197 | 55 | 4 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | distal-1-Hematologic-Plasmacytoid_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-04 | 197 | 55 | 4 | 166d47359df9279ea8c3946f10bd3d4b88c95857 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-04 | 197 | 55 | 4 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 198 | 55 | 4 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 199 | 55 | 4 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 1.15e-04 | 203 | 55 | 4 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 97 | 55 | 3 | 1da964954a95c497ac4a24df1ea3575df5747025 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 97 | 55 | 3 | dd188763ba02337e4f25d56766eda886cffa810d | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 97 | 55 | 3 | a0242258aad0766450ff52fe28278cbb2b8d63a0 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 97 | 55 | 3 | 98a31b9bf0adcad1cb1d803bf7a23d49b4e1f2d5 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-dn_T|COVID-19_Mild / Disease group, lineage and cell class | 4.07e-04 | 117 | 55 | 3 | 9d417dd137c27f8fe9e57842cd5515fdc2f2dc06 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.07e-04 | 117 | 55 | 3 | e74dd01ccb6cc630759146655fccec359f725b1d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.07e-04 | 117 | 55 | 3 | 3c67e8a184b5a8302cba584e5ee97006f6cd267f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.18e-04 | 118 | 55 | 3 | d95344ef24a1a838232186c02725f556c5fd51ac | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.18e-04 | 118 | 55 | 3 | bc65345ee8e59fbda60f345696192376cdbf54b8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.18e-04 | 118 | 55 | 3 | c234ea1969726356ee47d9364b716044cfbd125a | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 4.72e-04 | 123 | 55 | 3 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-04 | 129 | 55 | 3 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh|GI_small-bowel / Manually curated celltypes from each tissue | 6.05e-04 | 134 | 55 | 3 | bf94ce5edde8912a27010e229c313d8102d6de62 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.18e-04 | 135 | 55 | 3 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 6.73e-04 | 139 | 55 | 3 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 7.16e-04 | 142 | 55 | 3 | 1175d4390d204ffa3a2d2fe24486f85d3b639b72 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-04 | 145 | 55 | 3 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-04 | 146 | 55 | 3 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.92e-04 | 147 | 55 | 3 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-04 | 147 | 55 | 3 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-04 | 147 | 55 | 3 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.07e-04 | 148 | 55 | 3 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.07e-04 | 148 | 55 | 3 | 065177aaa63c0441d312260b43ecdac78c84ad03 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 8.23e-04 | 149 | 55 | 3 | 75422e1a22736375e9ef439db0b2a5efa3f653a3 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.23e-04 | 149 | 55 | 3 | 68661c8facfb638560bb2e2c20d509941286dacb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-04 | 151 | 55 | 3 | c1461d0dd622a081187eba77f454d2663df2732e | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 8.55e-04 | 151 | 55 | 3 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 8.55e-04 | 151 | 55 | 3 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.55e-04 | 151 | 55 | 3 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 8.72e-04 | 152 | 55 | 3 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-04 | 152 | 55 | 3 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.72e-04 | 152 | 55 | 3 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.72e-04 | 152 | 55 | 3 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.72e-04 | 152 | 55 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-04 | 152 | 55 | 3 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.89e-04 | 153 | 55 | 3 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | Influenza_Severe-CD4+_CTL|World / Disease group and Cell class | 8.89e-04 | 153 | 55 | 3 | 0c6c2c6dbc81badd886f125f4e5ba0fb7d52101c | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.89e-04 | 153 | 55 | 3 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.89e-04 | 153 | 55 | 3 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 9.06e-04 | 154 | 55 | 3 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-04 | 154 | 55 | 3 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.23e-04 | 155 | 55 | 3 | d8e9f355ce933f6383c3d1e35ff55235a95c7fcd | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-04 | 155 | 55 | 3 | a16e3a72badafa78a3efc4f4ab62396f0ce99d1e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.40e-04 | 156 | 55 | 3 | 84f01419d8c116714e8c8c857c4d153a755b7867 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 9.40e-04 | 156 | 55 | 3 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-04 | 156 | 55 | 3 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.40e-04 | 156 | 55 | 3 | 2285be9746d0d0f62a488b9c64fa67a834758dd7 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-04 | 156 | 55 | 3 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | PBMC-Mild-cDC_6|Mild / Compartment, Disease Groups and Clusters | 9.40e-04 | 156 | 55 | 3 | 3db686849844120b3e376599929d11ad06f0d577 | |
| Computational | Metal / Ca ion binding. | 4.14e-05 | 133 | 32 | 5 | MODULE_324 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 1.03e-05 | 25 | 50 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | apolipoprotein A-IV measurement | 2.80e-05 | 5 | 50 | 2 | EFO_0007848 | |
| Disease | Familial aplasia of the vermis | 5.24e-04 | 20 | 50 | 2 | cv:C0431399 | |
| Disease | sorbitol measurement | 6.96e-04 | 23 | 50 | 2 | EFO_0010533 | |
| Disease | chronic hepatitis B virus infection | 7.58e-04 | 24 | 50 | 2 | EFO_0004239 | |
| Disease | L-arginine measurement | 9.61e-04 | 27 | 50 | 2 | EFO_0006524 | |
| Disease | glycine measurement | 1.64e-03 | 137 | 50 | 3 | EFO_0009767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGWYVGVCRDDVDRG | 351 | Q6UXE8 | |
| GTSEIICLGGGRRVW | 1216 | Q7Z407 | |
| DTSQSGEDGGCWQRE | 261 | Q9NPI1 | |
| GEDGGCWQREREDSG | 266 | Q9NPI1 | |
| RGGWSDNGCSVKDRR | 581 | Q8IZP9 | |
| GRGSWADAREQVVGD | 1471 | Q5H9R4 | |
| VRHGSDENCRSWNEG | 186 | Q52LD8 | |
| QRRTCQEGGSWSGTE | 201 | P00751 | |
| GRVEIQRAGEWGTIC | 56 | P58215 | |
| GTEQSVTECASRGWG | 116 | P58215 | |
| IGVQEGCSDRREWET | 336 | Q9NRR6 | |
| GAVDRTESGRECQRW | 171 | Q2TV78 | |
| ENRGNEGTCVGVSRW | 2081 | Q15751 | |
| GEQGTVACTWERGRD | 136 | Q99665 | |
| CIGGFWREVGVASDQ | 31 | Q6JVE9 | |
| TEGFRGWNGQCLDVD | 1026 | Q14766 | |
| DGGWGEDFESCEERR | 626 | P48449 | |
| REGWNRFICDCIGTG | 706 | Q9P2S2 | |
| GQGAGEVWLRVDCRN | 51 | Q9BYJ0 | |
| DSRILVCGGDGTVGW | 426 | P23743 | |
| WSIGGSCDTDGRRVF | 1781 | Q6ZR08 | |
| QARCRGEQISGTVGW | 646 | Q7Z7M0 | |
| RELCWREGPGTDQTE | 126 | Q92985 | |
| GRTFRDAQSWCEGQG | 46 | Q7Z442 | |
| GEEDEQGWCRGRLDS | 416 | Q9BY11 | |
| ESENRVSEGRWGRGC | 46 | Q9P1J3 | |
| DTDGGGWTVFQRRVD | 136 | Q15485 | |
| IDNDGGWVDITRQGR | 346 | Q9H336 | |
| CQGSGREVWGDIVDA | 996 | Q8N1P7 | |
| GFTWRGGCERETTGI | 136 | Q8NHH9 | |
| GGCERETTGIQVWNE | 141 | Q8NHH9 | |
| TSWGEGCARREQPGV | 596 | P03952 | |
| GQASRRWLQEGGQEC | 36 | Q6UXB2 | |
| GAVDRTESGRECQRW | 201 | P26927 | |
| VSVNEGRWVRGCSAG | 431 | P20807 | |
| IRNSTGERGELSCGW | 476 | O15259 | |
| AGNRGWAGTREEVRD | 6 | Q96GU1 | |
| GRGGELETICRSWND | 61 | Q496H8 | |
| AREGVGCSWESGRAE | 271 | Q7Z6J9 | |
| EAGEIRWGAEGRDVC | 136 | Q9UIG8 | |
| GRQEGWCRDSTTDEQ | 336 | Q92696 | |
| MWRVEREGTGLTEGC | 111 | Q8NB12 | |
| DDCWQGVNGSVGISR | 451 | Q2M3G4 | |
| RGGGACLQARTWSVD | 1871 | Q99466 | |
| CIFRTDDGRGWGVRT | 246 | O43463 | |
| ERQGDVTCVCGVGWA | 441 | P35443 | |
| IQGRNVSRSCTDEGW | 96 | P32241 | |
| VSCWFENAEGQERGG | 161 | Q6P1L6 | |
| EVEVGDRSEWGLGVC | 361 | Q6AZZ1 | |
| VENGGVTRWEECSNR | 326 | O95210 | |
| CCVTAGGRDGTVRVW | 296 | O43818 | |
| TGGCDGAVRVWDIVR | 126 | Q12788 | |
| STREWASRCGIGQEE | 786 | Q9C0C2 | |
| GTRCVITGWGSVREG | 946 | Q7Z410 | |
| SRCDGRVEVSLDGVW | 441 | Q4G0T1 | |
| CEWRQGDGKGITRNF | 541 | P07949 | |
| DAGRYWCQVEDGGET | 111 | Q06418 | |
| GRAGDCARSSWGEEQ | 521 | Q8WXH2 | |
| CARSSWGEEQAGGSR | 526 | Q8WXH2 |